Kaival Brands Innovations Group, Inc. (KAVL) SEC Filings

Kaival Brands Innovations Group, Inc. (KAVL) reported that director Mark L. Thoenes received a grant of 250,000 non-qualified stock options on August 15, 2026 under the Amended and Restated 2020 Stock and Incentive Compensation Plan. The options have an exercise price of $0.0273 per share and now bring his reported option holdings to 750,000 options.

The award vests in full on the earlier of December 31, 2026 or a Change in Control, subject to his continued service as a director, and expires on August 15, 2036. No Rule 10b5-1 trading plan is reported for this grant.

Kaival Brands Innovations Group, Inc. (KAVL) reported very limited royalty-based revenue and continued losses for the quarter ended July 31, 2026, while explicitly stating substantial doubt about its ability to continue as a going concern. Revenue came solely from Philip Morris International royalties and fell to $55,254 for the quarter and $185,722 year-to-date. Operating expenses dropped sharply to $314,422 for the quarter and $1.64 million for the nine months, compared with $700,944 and $7.02 million in the prior-year periods, significantly narrowing the net loss to $243,868 for the quarter and $1.44 million year-to-date. Cash was only $133,221 with a working capital deficit of $265,407, and management indicates additional capital is needed to fund operations, with U.S. distribution of BIDI Stick products ceased and primary dependence on PMI license royalties.

Kaival Brands Innovations Group reports another weak quarter with a small revenue base and ongoing losses. For the quarter ended April 30, 2026, revenue was about $37,000, almost entirely from royalties under its international licensing agreement with Philip Morris Products, down from roughly $47,000 a year earlier. The company recorded a net loss of about $575,000 for the quarter and $1.2 million for the first six months, though both losses narrowed sharply versus the prior year as operating expenses fell from prior elevated levels.

Cash was $278,000 and management disclosed a working capital deficit and substantial doubt about the company’s ability to continue as a going concern without new funding. Kaival no longer earns revenue from U.S. BIDI Stick distribution because of FDA marketing denial orders and an International Trade Commission patent case, leaving it heavily reliant on Philip Morris royalties and potential monetization of GoFire intellectual property. The company also holds significant outstanding stock options and warrants, which could dilute shareholders if exercised.

Kaival Brands Innovations Group, Inc. CFO Eric Morris reported new equity compensation awards. He received a restricted stock award covering 3,000,000 shares of common stock, with 600,000 shares vesting immediately and 2,400,000 vesting in 200,000-share quarterly installments over the next 12 fiscal quarters, subject to continued service.

He was also granted a non-qualified stock option for 3,000,000 shares of common stock at an exercise price of $0.0152 per share, expiring on March 31, 2036. Of these options, 600,000 vested immediately and 2,400,000 will vest in equal 200,000-option quarterly installments over 12 fiscal quarters, subject to continued service. Following the award, he directly holds 3,006,020 shares of common stock and 3,000,000 stock options.

Kaival Brands Innovations Group CEO Eric Mosser received significant equity compensation grants. He was awarded a restricted stock award for 3,000,000 shares of common stock, with 600,000 shares vesting immediately and 2,400,000 vesting in 200,000-share installments each fiscal quarter over the next 12 quarters, subject to continued service.

He also received a non-qualified stock option to purchase 3,000,000 shares at an exercise price of $0.0152 per share, with 600,000 options vesting immediately and the remaining 2,400,000 vesting in equal quarterly installments over the next 12 quarters. In addition, he was granted a non-qualified stock option for 586,060 shares at $0.0152 per share, with 25% vesting immediately and 75% vesting in quarterly installments over the next three fiscal quarters, all under the Amended and Restated 2020 Stock and Incentive Compensation Plan.

Kaival Brands Innovations Group director Mark L. Thoenes received a grant of stock options as equity compensation. He was awarded options to buy 500,000 shares of common stock at an exercise price of $0.0152 per share, expiring on March 31, 2036.

The options were granted under the company’s Amended and Restated 2020 Stock and Incentive Compensation Plan. They vest in four equal quarterly installments of 125,000 options at the end of each fiscal quarter over the next four quarters, subject to his continued service with the company.

Kaival Brands Innovations Group, Inc. updated its leadership compensation structure by approving new employment agreements for its Chief Executive Officer and Chief Financial Officer on March 31, 2026. The agreements emphasize equity-based pay tied to recovery milestones to support the company’s post-Nasdaq delisting recovery plan while preserving cash.

The Board, acting under DGCL §144, relied on a fairness opinion from its sole disinterested director, who concluded the arrangements are fair and reasonable to the company and its stockholders from a financial point of view. The Board also amended the Amended and Restated 2020 Stock and Incentive Compensation Plan to increase the maximum aggregate shares available under the plan to 100,000,000 shares, further aligning executive incentives with long-term stockholder value.

Kaival Brands Innovations Group, Inc. reported a net loss of $620,787 for the quarter ended January 31, 2026, compared with a loss of $4,061,080 a year earlier. Quarterly revenue was $92,938, down from $202,603, and now comes entirely from royalty income under its Philip Morris international licensing agreement.

Cash increased to $797,500 and working capital to $497,068, helped by $1,015,443 of common share issuance, but operations used $752,349 of cash. The company has ceased Bidi Stick distribution in the U.S. following FDA marketing denial orders and an ITC patent case, and explicitly warns of substantial doubt about its ability to continue as a going concern without additional capital.

Kaival Brands Innovations Group reported major governance changes as it adjusts to trading on the OTC market after its Nasdaq delisting. The board accepted the resignations of directors David Worner, Ketankumar Patel, and Ashesh Modi, effective January 31, 2026, citing cost-saving and governance streamlining, with no disagreements on company matters. Interim CEO Mark Thoenes also resigned effective February 5, 2026. The board appointed Eric Mosser as Chief Executive Officer, highlighting his prior role leading transactions such as an international licensing deal with Philip Morris International and overseeing operations that generated nearly $120 million in revenue within 12 months. Using unanimous written consent, the board also approved amended and restated bylaws and a certificate of amendment, effective February 5, 2026, to enhance governance efficiency and support the company’s recovery plan, actions that did not require stockholder approval.